|
|
Previous Article | Table of Contents | Next Article 
Identification of a point mutation in factor XIII A subunit deficiency
P Board, M Coggan and K Miloszewski
Molecular Genetics Group, John Curtin School of Medical Research,
Australian National University, Canberra.
Oligonucleotide primers have been designed for the amplification of all 15
exons of the human coagulation factor XIII A subunit gene. Each exon and
its intron flanking regions has been amplified and sequenced from a patient
with severe A subunit deficiency. A single G to A transition in the last
base of exon 14 has been identified in the homozygous proband and in his
heterozygous parents. The mutation would result in the substitution 681 Arg
to His in the mature protein product. However, because the mutation is at a
splice junction, the deficiency may result from a defect in pre-messenger
RNA splicing.
Volume 80,
Issue 4,
pp. 937-941,
08/15/1992
Copyright © 1992 by The American Society of Hematology

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. Kangsadalampai, G. Chelvanayagam, R. T. Baker, P.-t. Yenchitsomanus, P. Pung-amritt, C. Mahasandana, and P. G. Board
A Novel Asn344 Deletion in the Core Domain of Coagulation Factor XIII A Subunit: Its Effects on Protein Structure and Function
Blood,
July 15, 1998;
92(2):
481 - 487.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Takahashi, H. Tsukamoto, H. Umeyama, G. Castaman, F. Rodeghiero, and A. Ichinose
Molecular Mechanisms of Type II Factor XIII Deficiency: Novel Gly562-Arg Mutation and C-Terminal Truncation of the A Subunit Cause Factor XIII Deficiency as Characterized in a Mammalian Expression System
Blood,
April 15, 1998;
91(8):
2830 - 2838.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Huber, V. C. Yee, N. Burri, E. Vikerfors, A. P. M. Lavrijsen, A. S. Paller, and D. Hohl
Consequences of Seven Novel Mutations on the Expression and Structure of Keratinocyte Transglutaminase
J. Biol. Chem.,
August 22, 1997;
272(34):
21018 - 21026.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Mikkola, L. Muszbek, E. Laiho, M. Syrjala, E. Hamalainen, G. Haramura, T. Salmi, L. Peltonen, and A. Palotie
Molecular Mechanism of a Mild Phenotype in Coagulation Factor XIII (FXIII) Deficiency: A Splicing Mutation Permitting Partial Correct Splicing of FXIII A-Subunit mRNA
Blood,
February 15, 1997;
89(4):
1279 - 1287.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S.-Y. Kim, S.-I. Chung, and P. M. Steinert
Highly Active Soluble Processed Forms of the Transglutaminase 1 Enzyme in Epidermal Keratinocytes
J. Biol. Chem.,
July 28, 1995;
270(30):
18026 - 18035.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|